Technology Investment Strategy Annex Collective Protection Front End Analysis and Master Plan Report

摘要

The Chemical Biological (CB) Tech Base program funds 6.2 projects to investigate and develop technologies for CB Defense. The program consists of several business areas, one of which is Collective Protection (CP). The CP business Area Manager (BAM) conducted a Front-end Analysis (FEA) to identify promising technologies for future applications. Candidate technologies were evaluated and ranked relative to performance, operational, and logistical factors. The FEA process identified several feasible technologies, and the CP BAM had to choose which technologies to invest in with a limited budget. The Decision Analysis Team created a Master Plan (MP) process to examine investment options and to develop an overall program funding strategy. Maturity, risk, and payoff were the major factors considered. The process enabled the BAM to construct several investment portfolios that reflected varying levels of risk and cost. The ultimate product from this process was a listing of 'Best Buys,' consisting of a combination of technologies at optimal funding levels; the 'Best Buy' package will yield the highest benefit for a specified budget. This effort established a new methodology using cost analysis and resource allocation methods to develop investment strategies. This process is repeatable, defensible, and allows for justifiable investment decisions.